Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nunavut Tunngavik Incorporated (NTI) is the legal representative of the Inuit of Nunavut, established to ensure the implementation of the Nunavut Agreement. While not a traditional pharmaceutical company, NTI is a key player in Arctic healthcare through its management of the Qanuippitaa? National Inuit Health Survey and its advocacy for Inuit self-determination in health policy. The organization funds and coordinates significant initiatives in tuberculosis elimination, suicide prevention, and community wellness. Additionally, NTI oversees bioprospecting agreements on Inuit-owned lands, ensuring that research into bioactive compounds for potential medical or cosmetic use provides equitable benefits to the Inuit community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nunavut Tunngavik.